How is the CRISPR Therapeutics AG today?

The CRISPR Therapeutics AG today is trading in the down by -4.32% at 40.97.

CRISPR Therapeutics AG XNAS: CRSP

CRISPR Therapeutics AG Live Share Price Today, Share Analysis and Chart

Name: CRISPR Therapeutics AG: Is Infosys Ltd. worth buying?
Item: CRISPR Therapeutics AG
Rating: 0.93541675
Author: Trendlyne DVM scores

Weak Stock

Download real time

40.97 -1.85 (-4.32%)

46.03% Fall from 52W High

1.9M XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

9.5 / 100

Technically Bearish

32.0 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

84

1Yr Price target upside is 104%

25 analysts

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CRISPR Therapeutics AG FAQ

How is CRISPR Therapeutics AG today?

CRISPR Therapeutics AG today is trading in the red, and is down by -4.32% at 40.97.

How has CRISPR Therapeutics AG performed historically?

CRISPR Therapeutics AG is currently trading down -4.32% on an intraday basis. In the past week the stock fell -5.47%. stock has been down -8.20% in the past quarter and fell -43.84% in the past year. You can view this in the overview section.